We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8M
AUM Growth
+$681K
(+3.1%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,939.41%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,409
New
162
Increased
850
Reduced
1,040
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$114M |
| 2 |
Cadence Design Systems
CDNS
|
+$112M |
| 3 |
Fortinet
FTNT
|
+$81.7M |
| 4 |
Cummins
CMI
|
+$68.3M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$93.3M |
| 2 |
Waters Corp
WAT
|
+$87.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$87M |
| 4 |
Automatic Data Processing
ADP
|
+$74.9M |
| 5 |
Amphenol
APH
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 13% |
| 3 | Financials | 12.4% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Vertex Pharmaceuticals
VRTX
$123B
| $424 | ﹤0.01% |
2,317
+409
| +21% | +$71.5K |
|
827
Mesa Laboratories
MLAB
$543M
| $421 | ﹤0.01% |
1,727
-22
| -1% | -$5.12K |
|
828
Broadridge
BR
$17.6B
| $418 | ﹤0.01% |
3,283
| – | – |
|
829
Avanos Medical
AVNS
$1.17B
| $415 | ﹤0.01% |
9,559
+851
| +10% | +$36.4K |
|
830
Essent Group
ESNT
$6.11B
| $414 | ﹤0.01% |
8,847
+1,705
| +24% | +$80.3K |
|
831
Teladoc Health
TDOC
$1.6B
| $414 | ﹤0.01% |
6,256
-3,637
| -37% | -$212K |
|
832
Columbia Banking Systems
COLB
$8.8B
| $412 | ﹤0.01% |
11,396
+2,378
| +26% | +$84.2K |
|
833
Invesco AI and Next Gen Software ETF
IGPT
$1.19B
| $412 | ﹤0.01% |
12,900
| – | – |
|
834
Choice Hotels
CHH
$5.1B
| $410 | ﹤0.01% |
4,713
-128
| -3% | -$10.7K |
|
835
JB Hunt Transport Services
JBHT
$26.8B
| $408 | ﹤0.01% |
4,476
+159
| +4% | +$15K |
|
836
Novanta
NOVT
$5.11B
| $408 | ﹤0.01% |
4,335
+1,500
| +53% | +$128K |
|
|
MRO
837
DELISTED
Marathon Oil Corporation
MRO
| $407 | ﹤0.01% |
28,711
-4,205
| -13% | -$65K |
|
838
eHealth
EHTH
$43.5M
| $405 | ﹤0.01% |
4,712
+4,635
| +6,019% | +$312K |
|
839
Pool Corp
POOL
$6.79B
| $405 | ﹤0.01% |
2,125
-327
| -13% | -$59K |
|
|
XYZ
840
Block Inc
XYZ
$47.7B
| $405 | ﹤0.01% |
5,595
-730
| -12% | -$51K |
|
|
USB.PRM
841
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
| $405 | ﹤0.01% |
+15,143
| New | +$409K |
|
842
Ligand Pharmaceuticals
LGND
$6.08B
| $400 | ﹤0.01% |
5,638
+351
| +7% | +$25.9K |
|
843
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
| $399 | ﹤0.01% |
10,320
+1,200
| +13% | +$45.6K |
|
844
BWX Technologies
BWXT
$16.4B
| $396 | ﹤0.01% |
7,621
-510
| -6% | -$25.5K |
|
|
CSFL
845
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $396 | ﹤0.01% |
17,224
+3,614
| +27% | +$84.8K |
|
|
TUP
846
DELISTED
Tupperware Brands Corporation
TUP
| $395 | ﹤0.01% |
20,811
-5,750
| -22% | -$129K |
|
847
TSMC
TSM
$2.08T
| $394 | ﹤0.01% |
10,076
+322
| +3% | +$13.3K |
|
848
Morningstar
MORN
$6.81B
| $391 | ﹤0.01% |
2,707
-200
| -7% | -$27.6K |
|
849
CAE Inc. Common Shares
CAE
$8.23B
| $390 | ﹤0.01% |
14,552
+411
| +3% | +$10K |
|
850
Shopify
SHOP
$159B
| $386 | ﹤0.01% |
12,890
+770
| +6% | +$20K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2019 Portfolio in Review
As of Q2 2019, Glenmede Trust held 3,409 positions worth $22.8M, up 3.1% from $22.1M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust withdrew a net $442M in Q2 2019, closing 145 positions and reducing 1,040 holdings. Its most notable exit was Sinclair Inc, an estimated $23.5K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Dow Inc worth $29.7K.
- Glenmede Trust's largest Q2 2019 buy was Dow Inc: 602,067 shares worth $29.7K.
- Glenmede Trust added most to Electronic Arts in Q2 2019, an estimated $114M increase.
- Glenmede Trust's biggest Q2 2019 reduction was Cognizant, cutting an estimated $93.3M.
- Glenmede Trust fully exited Sinclair Inc in Q2 2019, selling an estimated $23.5K.
- Glenmede Trust's ten largest holdings make up 14% of its $22.8M portfolio in Q2 2019.
- Glenmede Trust opened 162 new positions and closed 145 in Q2 2019.
- Glenmede Trust's portfolio value rose 3.1% quarter-over-quarter to $22.8M.
Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.